Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment target
~394 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated December 2023